Correction to “Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity”

The affiliation for author Matthias Olfert is to be changed. The correct affiliation for where Mr. Olfert was when the work was done for the originally published paper is: Institute of Pharmacy, Pharmaceutical (Bio-)Analysis, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany. The changes are reflected in the authorship and Supporting Information of this Correction.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsptsci.4c00095.

• GSH studies of 9b, 11b, and 11e (Figure S1, Table S1), metabolic stability studies of 11b and 11e (Table S2), the chemical structure of XU3 and 11g (Figure S2), molecular modeling (Figure S3), and ¹H and ¹³C NMR spectra of representative compounds (Figures S4–S24) (PDF)